1. Doçi, Colleen L, Mankame, Tanmayi P, Langerman, Alexander, Salgia, Ravi, Lingen, Mark W. . Characterization of NOL7 gene point mutations, promoter methylation, and protein expression in cervical cancer. In International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists, 31, 15-24. doi:10.1097/PGP.0b013e318220ba16. https://pubmed.ncbi.nlm.nih.gov/22123719/
2. Mankame, Tanmayi P, Zhou, Guolin, Lingen, Mark W. 2010. Identification and characterization of the human NOL7 gene promoter. In Gene, 456, 36-44. doi:10.1016/j.gene.2010.02.008. https://pubmed.ncbi.nlm.nih.gov/20206243/
3. Kinor, Noa, Shav-Tal, Yaron. . The dynamics of the alternatively spliced NOL7 gene products and role in nucleolar architecture. In Nucleus (Austin, Tex.), 2, 229-45. doi:10.4161/nucl.2.3.15893. https://pubmed.ncbi.nlm.nih.gov/21818416/
4. Hasina, R, Pontier, A L, Fekete, M J, Coignet, L J, Lingen, M W. . NOL7 is a nucleolar candidate tumor suppressor gene in cervical cancer that modulates the angiogenic phenotype. In Oncogene, 25, 588-98. doi:. https://pubmed.ncbi.nlm.nih.gov/16205646/
5. Liu, Qiaojun, Xie, Renjian, Li, Yumei. 2022. Pancancer Analysis of the Oncogenic and Prognostic Role of NOL7: A Potential Target for Carcinogenesis and Survival. In International journal of molecular sciences, 23, . doi:10.3390/ijms23179611. https://pubmed.ncbi.nlm.nih.gov/36077008/
智鼠故事 
